Citius Oncology, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update

CRANFORD, N.J., Dec. 27, 2024 /PRNewswire/ — Citius Oncology, Inc. (“Citius Oncology” or the “Company”) (Nasdaq: CTOR), a specialty biopharmaceutical company focused on the development and commercialization of novel targeted oncology therapies, today reported business and financial results for the…